|
Treatment of Osteoporosis
A complete treatment program for osteoporosis
should include:
- medication to help maintaining
bone denisty and reducing pain
- a healthy eating program which
ensures adequate intake of calcium, vitamins and
minerals
- a good exercise program which
facilitates healthy bone growth and muscle strengthening
Medication for osteoporosis
The latest treatments can reduce
bone loss, increase bone density and reduce
the incidence of fractures. They are:
|
| |
1. Alendronate (FOSAMAX)
2. Risedronate (ACTONEL)
3. Raloxifene (Evista)
4. Calcitonin
5. Hormone Replacement Therapy (HRT) |
1. Alendronate
Well-conducted clinical trials utilizing alendronate
sodium indicate that treatment reduces the incidence
of fracture at the spine, hip, and wrist by 50% in
patients with osteoporosis. Alendronate must be taken
on an empty stomach, first thing in the morning, with
a large glass of water, at least 30 minutes before
eating or drinking. Patients should remain upright
during this interval. Although in clinical trials the
incidence of side effects was no different than placebo,
clinical experience suggests that some patients will
experience upper gastrointestinal disturbance, particularly
esophageal symptoms (chest pain, heartburn, painful
or difficult swallowing)
2. Risedronate
Studies showed that 5mg of risedronate slows bone
loss, increase bone density and reduces the risk of
spine and non-spine fractures. Risedronate must be
taken on an empty stomach, first thing in the morning
with a glass of water. The patients should remain upright
and refrain from eating, drinking or taking other medications
for at least 30 minutes after taking risedronate. Few
side effects were reported included stomach upset,
constipation, diarrhea, bloating, gas or headache.
3. Raloxifene
This drug is in a class of compounds called selective
estrogen receptor modulators (SERMS), which have been
developed to provide the beneficial effects of estrogen
without their potential disadvantages. Raloxifene has
been shown to prevent bone loss, and preliminary data
in women with osteoporosis show that it reduces the
risk of vertebral fracture by 40-50%. Raloxifene increases
the risk of deep vein thrombosis to a degree similar
to that observed with estrogen. In addition, an increase
in hot flashes is observed, and it cannot be used to
treat menopausal symptoms.
4. Calcitonin
It is delivered as a single daily nasal spray that
provides 200 units of the drug. Efficacy data for calcitonin
are weaker than for either HRT or alendronate.
5. Hormone Replacement Therapy,
HRT
Many women will benefit from the effects of HRT on
bone and possibly other organ systems. Since HRT may
be associated with a modest increase in risk of breast
cancer with long term use and deep vein thrombosis,
women with a history of, or at significant risk for,
these conditions may consider using other alternative
methods. Some patients on HRT may experience some side
effects, including vaginal bleeding, breast tenderness,
mood disturbances, and gallbladder disease.
6. Relieving pain
Osteoporosis without fractures or complications does
not produce pain. It is usually the fractures that
cause pain. One should not neglect the pain caused
by acute compression fracture of the spine. Treat pain
as normally and alendronate or calcitonin actually
also helps to relieve pain caused by fractures.
Source of information:National Osteoporosis Foundation
|
|
|